
    
      The study population has metastatic rectal cancer. After obtaining informed consent and if
      they fulfil all of the criteria for inclusion, patients will be included.

      After 8 weeks of induction chemotherapy with FOLFOX, patients perform an imaging assessment.

      Then they are treated by radiotherapy with an oral Xeloda At the end of irradiation, patients
      realize on other Imaging assessment. Patients are then followed for 2 years
    
  